A 58-year-old male presents with a painful, enlarging mass in the distal anterior thigh. He has a history of high-grade pleomorphic undifferentiated sarcoma (PUS) in the same limb, treated 2 years ago with wide local excision and 60 Gy of adjuvant radiotherapy. Physical exam reveals a firm, 8x6 cm deep-seated mass. How would you structure your immediate clinical approach to this patient?
Candidate: I would start by performing a thorough history and physical exam to assess for local recurrence or systemic symptoms. I would order an MRI of the entire thigh with contrast to assess the local extent, and a CT of the chest to rule out pulmonary metastasis. I would then perform a biopsy to confirm recurrence before discussing the case at a multidisciplinary tumor board.
Candidates often jump straight to diagnostic tests without mentioning the absolute necessity of a Multidisciplinary Team (MDT) early in the pathway. They may also fail to highlight the importance of biopsy planning—failing to mention that the biopsy must be taken through a site that can be excised en-bloc during definitive surgery, which is critical in previously irradiated fields.
A high-scoring answer follows a structured approach: 1. Clinical Assessment: Confirm M0 status (systemic symptoms, CT chest/abdomen). 2. Imaging: MRI is mandatory for local staging, assessing neurovascular bundle (NVB) involvement and proximity to the femur. 3. Biopsy: Image-guided core needle biopsy, ensuring the tract is placed so it can be excised with the final specimen. 4. MDT: Emphasize the MDT role in oncology, as this is a recurrent high-grade lesion in a previously irradiated field, requiring complex reconstructive planning (e.g., plastic surgery for free flaps) and careful assessment of resectability vs. amputation.
The imaging confirms the mass is abutting the femoral neurovascular bundle and the anterior femoral cortex. Given the prior radiotherapy, what are your primary concerns regarding surgical management, and how do you counsel the patient regarding "limb salvage"?
Candidate: My main concern is that the prior radiation makes tissue planes difficult to define and wound healing problematic. I would counsel the patient that while we aim for limb salvage, we need wide margins, which might involve resecting muscles or vessels. If we can't achieve a margin without compromising neurovascular structures, we have to discuss amputation.
Missing the concept of R0 resection. Candidates often focus too much on limb salvage at the expense of oncologic control. Failing to acknowledge that "limb salvage is not always the best oncologic choice" is a major red flag. They often fail to mention the specific risk of wound healing complications inherent to previously radiated tissue.
A structured response includes: 1. Oncologic Priority: State clearly that R0 (negative) margins are the priority. 2. Tissue Biology: Explain that prior radiotherapy creates "stiff," poorly vascularized tissue, increasing the risk of wound dehiscence and deep infection. 3. Reconstructive Planning: Mention the necessity of flap coverage (e.g., ALT free flap) rather than primary closure. 4. Patient Counselling: Use a shared decision-making model to discuss the functional trade-offs; if an R0 margin cannot be achieved or if the resulting limb would be non-functional (e.g., due to nerve resection), amputation is a medically sound, curative alternative that must be on the table.
Detailed Chapters & Topics
Dive deeper into specialized chapters regarding orthopedic-oncology-cases-soft-tissue-sarcoma